http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004224935-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fa9a2244bcefb810096034dd8bb5827 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate | 2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446c7ee8a7514c691d27c93759289622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34fee6d9a1881f588f48b010903edbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45165b2af61477323b0cc80f4b8fc13e |
| publicationDate | 2004-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004224935-A1 |
| titleOfInvention | Topical antiandrogenic steroids |
| abstract | Steroidal antiandrogens and pharmaceutical compositions thereof, are used for reduction of the risk of developing, or for treatment of, androgen-dependent skin related diseases. In preferred embodiments, the antiandrogen EM-3180 is used for reduction of the risk of developing, or the treatment, of acne, seborrhea, hirsutism or androgenic alopecia: n n n Methods of treatment utilize the antiandrogen alone, or in combination with other active ingredients such as an inhibitor of a 5α-reductase, an inhibitor of type 5 17β-hydroxysteroid dehydrogenase, and/or an inhibitor of prostate short-chain dehydrogenase/reductase. |
| priorityDate | 2003-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 386.